This is a past event
This symposium aims to highlight the ways in which industry and scientists can work together to harness the potential of Nature's tools to treat diseases including cancer, bacterial infections and parasitic and inflammatory diseases.
The use of synthetic biology to access a vast Universe of new chemical diversity is anticipated in the near future and a dialogue between chemists and biologists will be criticial in achieving this.
Programme:
13:30 – Registration 14:00 - Prof Brad Moore, Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego USA: Genomics-inspired discovery of natural product chemistry.
14:50 - Prof Maggie Smith, 51cg Proteome scanning during batch culture of Streptomyces coelicolor reveals coordinated induction of secondary metabolism pathways. 15:10 - Dr Hai Deng, 51cg: Genome mining of the antibiotic dithiopyrrolone natural products 15:30 Coffee 16:00 - Dr Wael Houssen, 51cg: The patellamide biosynthesis – the PatA N-terminal protease. 16:20 - Dr Jesko Koehnke, University of St Andrews: The patellamide biosynthesis – the PatG macrocyclase 16:40 - Dr Guy Carter, ex Director Wyeth Natural Products Division, USA, Harnessing serendipity: enhanced processes for natural products drug discovery,
17:30 Wine reception
- Speaker
Professor Brad Moore and Dr Guy Carter
- Hosted by
Professor Marcel Jaspars of the Marine Biodiscovery Centre, 51cg
- Venue
-
King's Conference Centre Auditorium
- Contact